Leavell Investment Management Has Decreased Its Stericycle Com (SRCL) Position; Foundation Medicine Has 1.08 Sentiment

July 17, 2017 - By test

Leavell Investment Management Inc decreased Stericycle Inc Com (SRCL) stake by 42.6% reported in 2016Q4 SEC filing. Leavell Investment Management Inc sold 7,643 shares as Stericycle Inc Com (SRCL)’s stock declined 1.87%. The Leavell Investment Management Inc holds 10,300 shares with $794,000 value, down from 17,943 last quarter. Stericycle Inc Com now has $6.53 billion valuation. The stock increased 0.43% or $0.33 on July 14, reaching $76.3. About shares traded. Stericycle Inc (NASDAQ:SRCL) has declined 14.12% since July 17, 2016 and is downtrending. It has underperformed by 30.82% the S&P500.

Foundation Medicine, Inc. is a molecular information company. The company has market cap of $1.36 billion. The Firm sells products that are enabled by its molecular information platform to physicians and biopharmaceutical companies. It currently has negative earnings. It is engaged in the business of delivering molecular information about cancer to its customers.

Among 15 analysts covering Stericycle (NASDAQ:SRCL), 5 have Buy rating, 3 Sell and 7 Hold. Therefore 33% are positive. Stericycle had 38 analyst reports since August 14, 2015 according to SRatingsIntel. The firm earned “Underperform” rating on Friday, April 29 by RBC Capital Markets. Robert W. Baird downgraded it to “Neutral” rating and $130 target in Friday, October 23 report. The stock of Stericycle Inc (NASDAQ:SRCL) has “Sell” rating given on Monday, June 26 by RBC Capital Markets. Oppenheimer downgraded the stock to “Perform” rating in Friday, October 23 report. On Friday, October 23 the stock rating was maintained by Macquarie Research with “Outperform”. The rating was downgraded by Robert W. Baird to “Underperform” on Friday, May 5. The firm earned “Buy” rating on Friday, October 28 by Stifel Nicolaus. Jefferies maintained the stock with “Buy” rating in Friday, July 7 report. Wedbush maintained Stericycle Inc (NASDAQ:SRCL) on Monday, May 2 with “Neutral” rating. As per Monday, November 30, the company rating was maintained by RBC Capital Markets.

Investors sentiment increased to 0.85 in Q4 2016. Its up 0.08, from 0.77 in 2016Q3. It is positive, as 81 investors sold SRCL shares while 187 reduced holdings. 82 funds opened positions while 147 raised stakes. 78.81 million shares or 2.60% more from 76.82 million shares in 2016Q3 were reported. 106,289 were accumulated by First Trust Advsr Ltd Partnership. The Wisconsin-based Northwestern Mutual Wealth Management Communication has invested 0% in Stericycle Inc (NASDAQ:SRCL). Indiana-based Goelzer Investment Mgmt has invested 0.26% in Stericycle Inc (NASDAQ:SRCL). Symons Capital Management Incorporated reported 105,479 shares or 1.98% of all its holdings. M&T Comml Bank Corp reported 0.01% in Stericycle Inc (NASDAQ:SRCL). Fort Washington Invest Advsr Inc Oh reported 847,971 shares. Paloma Prtn Mgmt Comm owns 48,327 shares. Eagle Asset Inc invested in 0.02% or 31,774 shares. 751,846 are owned by Alliancebernstein L P. Employees Retirement Systems Of Texas, Texas-based fund reported 5,000 shares. Northern Tru reported 987,874 shares or 0.02% of all its holdings. Profund Advsr Limited Liability Company has 2,844 shares. Oregon Employees Retirement Fund holds 0.01% or 8,845 shares. Riverbridge Partners holds 528,594 shares or 0.85% of its portfolio. Telemus Capital Ltd reported 2,659 shares.

Leavell Investment Management Inc increased Schwab Strategic Tr Intl Eqty (SCHF) stake by 41,326 shares to 61,283 valued at $1.70 million in 2016Q4. It also upped J P Morgan Chase & Co Com (NYSE:JPM) stake by 4,673 shares and now owns 59,022 shares. Vanguard World Fd Mega Cap Val (MGV) was raised too.

Since February 1, 2017, it had 2 insider purchases, and 0 selling transactions for $326,368 activity. ZAFIROVSKI MIKE S had bought 2,920 shares worth $250,150. Murley Robert S also bought $76,218 worth of Stericycle Inc (NASDAQ:SRCL) shares.

Analysts await Stericycle Inc (NASDAQ:SRCL) to report earnings on August, 3 after the close. They expect $1.13 EPS, down 4.24% or $0.05 from last year’s $1.18 per share. SRCL’s profit will be $96.71 million for 16.88 P/E if the $1.13 EPS becomes a reality. After $1.09 actual EPS reported by Stericycle Inc for the previous quarter, Wall Street now forecasts 3.67% EPS growth.

The stock decreased 2.01% or $0.8 on July 14, reaching $39.05. About shares traded. Foundation Medicine Inc (FMI) has risen 124.70% since July 17, 2016 and is uptrending. It has outperformed by 108.00% the S&P500.

Analysts await Foundation Medicine Inc (NASDAQ:FMI) to report earnings on August, 1 after the close. They expect $-1.08 EPS, down 28.57% or $0.24 from last year’s $-0.84 per share. After $-1.31 actual EPS reported by Foundation Medicine Inc for the previous quarter, Wall Street now forecasts -17.56% EPS growth.

Gilder Gagnon Howe & Co Llc holds 0.56% of its portfolio in Foundation Medicine Inc for 1.60 million shares. Alphamark Advisors Llc owns 38,981 shares or 0.36% of their US portfolio. Moreover, Oppenheimer & Co Inc has 0.36% invested in the company for 703,581 shares. The New York-based Needham Investment Management Llc has invested 0.26% in the stock. Lombard Odier Asset Management (Usa) Corp, a New York-based fund reported 89,164 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.